AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351 (k) biosimilar pathway, today announced that ...
advising of actions it has taken or will take to regain compliance with the continued listing standards by August 3, 2026. If NYSE Regulation determines to accept the Plan, the Company will be ...
FISCALNOTE REGAINS COMPLIANCE WITH NYSE CONTINUED LISTING STANDARD; Recent Stock Price Appreciation Secures Company’s Recompliance ...
Belpointe PREP, LLC announced that it has regained compliance with NYSE American listing standards after successfully completing its 2024 Annual Meeting of Unitholders on January 28, 2025.
The Company was originally notified by NYSE American of non-compliance with the continued listing standards as a result of rescheduling our 2024 Annual Meeting in 2025. With the meeting now ...
Inc. ("Four Seasons Education" or the "Company") (NYSE: FEDU), a tourism and education-related service provider in China, today announced that it has received a letter from the New York Stock Exchange ...